ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,628.40
      -0.10%
      US Tech 100
      20,086.80
      -0.16%
      Dow Jones
      39,858.62
      0.35%
      Brent Oil
      84.655
      -0.46%
      Bitcoin
      58,304.92
      0.96%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) News

      RDHL

      Redhill Biopharma (RDHL)

      Redhill Biopharma Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RDHL
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      11/22/20214:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RDHLRedhill Biopharma Ltd
      11/19/20219:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/19/20219:09AMPR Newswire (US)RedHill Biopharma Announces Pricing of $15.5 Million Public Offering of American Depositary SharesNASDAQ:RDHLRedhill Biopharma Ltd
      11/18/20214:11PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/18/20214:03PMPR Newswire (US)RedHill Biopharma Announces Underwritten Public Offering of American Depositary SharesNASDAQ:RDHLRedhill Biopharma Ltd
      11/17/20217:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/15/20217:28AMInvestorsHub NewsWireRedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021NASDAQ:RDHLRedhill Biopharma Ltd
      11/15/20217:00AMPR Newswire (Canada)RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      11/15/20217:00AMPR Newswire (US)RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      11/15/20217:00AMPR Newswire (US)RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      11/09/20217:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      11/09/20217:00AMPR Newswire (US)RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021NASDAQ:RDHLRedhill Biopharma Ltd
      11/08/20217:15AMInvestorsHub NewsWireRedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHillNASDAQ:RDHLRedhill Biopharma Ltd
      11/08/20217:00AMPR Newswire (Canada)RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHillNASDAQ:RDHLRedhill Biopharma Ltd
      11/08/20217:00AMPR Newswire (US)RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHillNASDAQ:RDHLRedhill Biopharma Ltd
      11/08/20217:00AMPR Newswire (US)RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHillNASDAQ:RDHLRedhill Biopharma Ltd
      10/25/20217:01AMPR Newswire (US)RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021NASDAQ:RDHLRedhill Biopharma Ltd
      10/20/20217:00AMPR Newswire (US)RedHill Biopharma to Present at the BIO-Europe 2021 ConferenceNASDAQ:RDHLRedhill Biopharma Ltd
      10/18/20217:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      10/18/20217:00AMPR Newswire (US)RedHill Biopharma Announces Insider BuyingNASDAQ:RDHLRedhill Biopharma Ltd
      10/12/20217:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      10/12/20217:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      10/12/20217:00AMPR Newswire (US)RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034NASDAQ:RDHLRedhill Biopharma Ltd
      10/06/20217:00AMPR Newswire (US)RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization RequirementsNASDAQ:RDHLRedhill Biopharma Ltd
      10/04/20218:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RDHLRedhill Biopharma Ltd
      10/04/20218:03AMInvestorsHub NewsWireRedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      10/04/20218:00AMPR Newswire (US)RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      10/04/20218:00AMPR Newswire (Canada)RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 PatientsNASDAQ:RDHLRedhill Biopharma Ltd
      09/23/20217:00AMPR Newswire (US)RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with AurobindoNASDAQ:RDHLRedhill Biopharma Ltd
       Showing the most relevant articles for your search:NASDAQ:RDHL